Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial.

Source:http://linkedlifedata.com/resource/pubmed/id/16935870

Download in:

View as

General Info

PMID
16935870